Gradient Investments’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,800	Closed	-$6.31K	–	1461
2023 Q4	$6.31K	Hold	3,800	–	–	﹤0.01%	936
2023 Q3	$7.3K	Hold	3,800	–	–	﹤0.01%	868
2023 Q2	$5.47K	Hold	3,800	–	–	﹤0.01%	938
2023 Q1	$7.98K	Hold	3,800	–	–	﹤0.01%	856
2022 Q4	$4.29K	Hold	3,800	–	–	﹤0.01%	958
2022 Q3	$6K	Hold	3,800	–	–	﹤0.01%	909
2022 Q2	$5K	Hold	3,800	–	–	﹤0.01%	891
2022 Q1	$6K	Hold	3,800	–	–	﹤0.01%	860
2021 Q4	$8K	Hold	3,800	–	–	﹤0.01%	843
2021 Q3	$15K	Hold	3,800	–	–	﹤0.01%	688
2021 Q2	$12K	Hold	3,800	–	–	﹤0.01%	727
2021 Q1	$8K	Hold	3,800	–	–	﹤0.01%	804
2020 Q4	$10K	Hold	3,800	–	–	﹤0.01%	694
2020 Q3	$10K	Hold	3,800	–	–	﹤0.01%	697
2020 Q2	$12K	Hold	3,800	–	–	﹤0.01%	614
2020 Q1	$7K	Hold	3,800	–	–	﹤0.01%	715
2019 Q4	$11K	Buy	+3,800	New	+$13.2K	﹤0.01%	671